Target intelligence / Profile preview

Membrane-associated phosphatidylinositol transfer protein 2 (PITPNM2)

Target
PITPNM2
Molecular classification
Lipid transfer protein, Membrane-associated protein, Other
01

Overview

Membrane-associated phosphatidylinositol transfer protein 2 (PITPNM2) is a member of the Class IIA phosphatidylinositol transfer proteins, homologous to the Drosophila retinal degeneration B (rdgB) protein, and is involved in the transfer of phosphatidylinositol and phosphatidylcholine between cell membranes[7][5]. PITPNM2 contains several domains, including a phosphatidylinositol transfer domain, and additional motifs aiding in its subcellular localization. It regulates the turnover of phosphoinositides and plays roles in signaling pathways dependent on phospholipase C activation, essential for lipid signaling and potentially for functions such as photoreceptor activity and neuronal physiology[1][5][7]. Downregulation or deficiency of PITPNM2 is linked to diseases such as retinal degeneration, cone-rod dystrophy, and is implicated as a risk factor in immune-mediated diseases like multiple sclerosis[7][1]. Its expression is noted in various human tissues, with particularly high expression in the retina and thymus[1]. There is also emerging evidence for involvement in some cancers through regulation of cell migration and signaling pathways[1].

Other names
KIAA1457NIR3PITPnm 2NIR-3RDGBA2RDGB2Phosphatidylinositol transfer protein, membrane-associated 2Pyk2 N-terminal domain-interacting receptor 3retinal degeneration B alpha 2
02

Biological functions

Lipid transfer (phosphatidylinositol and phosphatidylcholine transfer between membranes)Calcium ion bindingRegulation of phosphoinositide signalingInvolvement in phospholipase C (PLC) signaling pathwaysRegulation of PIP2 turnoverCell differentiation
03

Disease associations

Retinal degenerationCone-rod dystrophyMultiple sclerosis (risk factor)Allergic reactionPotential cancer relevance
04

Safety considerations

Downregulation implicated as a risk factor for multiple sclerosis and allergic reaction[1]Potential roles in cancer cell migration, but specific safety issues for direct targeting are not defined in current literature[1]

Beyond the preview

Go deeper on Membrane-associated phosphatidylinositol transfer protein 2 (PITPNM2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Membrane-associated phosphatidylinositol transfer protein 2 (PITPNM2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call